Pfizer Can't Keep Its Viagra Patent Up In Canada
from the no-quid,-no-quo dept
Today, in a ruling from the Supreme Court of Canada, Pfizer lost its Canadian patent on Viagra as the result of a long-fought battle with rival pharmaceutical manufacturer Teva, which sought to make a generic version of the popular drug. Though the patent was not set to expire until 2014, Teva argued (and the Supreme Court agreed, though lower courts had rejected the argument) that it was in fact never valid in the first place, because it was written in such a way as to obscure the information that is required disclosure in a patent:
P holds Patent 2,163,446 for the use of a “compound of formula (I)” or a “salt thereof” as a medicament for the treatment of erectile dysfunction (“ED”). The patent’s specification ends with seven cascading claims for successively smaller ranges of compounds, with Claims 6 and 7 relating to a single compound each. Only sildenafil, the subject of Claim 7 and the active compound in Viagra, had been shown to be effective in treating ED at the time of the patent application. Although the patent includes the statement that “one of the especially preferred compounds induces penile erection in impotent males”, the patent application does not disclose that the compound that works is sildenafil, that it is found in Claim 7, or that the remaining compounds had not been found to be effective in treating ED.
...
The patent application did not satisfy the disclosure requirements set out in the Patent Act, R.S.C. 1985, c. P‑4 (“Act”). The patent system is based on a “bargain”: the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge. Sufficiency of disclosure lies at the very heart of the patent system, so adequate disclosure in the specification is a precondition for the granting of a patent.
The ruling goes back to this all-important concept a few times: without disclosure, there can be no patent. It's good to see the court making this a central point, because pharma companies are notorious for attempting to twist the patent system so they get virtually perpetual monopolies on their drugs, while still shrouding their research and manufacturing methods in as much secrecy as possible. In the US, Pfizer had a similar showdown with Teva over generic Viagra starting in 2010, in which Pfizer won using a second patent that didn't cover the active compound in Viagra itself, but rather the marketing of it as an erectile dysfunction drug. Thus, even though the core patent on the drug expired this year, Pfizer will likely retain a monopoly on it until 2019. This is in stark contrast to the UK, where the patent on using the drug to treat ED was invalidated for obviousness way back in 2000—but Pfizer still dominates the market there thanks to related patents on manufacturing methods.
Basically, Pfizer uses any method it can think of to prevent its patents from ever expiring and benefiting the public the way patents are supposed to, including writing disclosures that obscure the necessary facts. The Supreme Court was having none of it—rather than letting Pfizer retroactively fix the disclosure, or coming up with any kind of partial remedy that allowed them to retain the patent, the ruling correctly states that patents must be a deal between two sides to function, and thus the patent is (and always has been) invalid:
Although s. 27 does not specify a remedy for insufficient disclosure, the quid pro quo underpinning the Act leads to the conclusion that deeming the patent invalid is the logical consequence of a failure to properly disclose the invention and how it works. If there is no quid — proper disclosure — then there can be no quo — exclusive monopoly rights.
...
There is no question that sildenafil’s utility had been demonstrated as of the time of filing of the patent application. This takes the invention out of the realm of sound prediction. As to the delay of 13 years between the filing of the patent and the challenge, the relevant question is whether the disclosure was sufficient as of the date of filing, so the delay is inconsequential.
This is a big victory for Teva and a major blow to Pfizer's Viagra empire, which is slowly crumbling around the globe. It's also likely to lead to even more illegal cross-border pharma sales, and even more of everyone's favorite email spam advertising online Canadian pharmacies—but that's another story.
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Filed Under: canada, disclosure, patents, viagra
Companies: pfizer, teva
Reader Comments
Subscribe: RSS
View by: Time | Thread
Kudos
[ link to this | view in thread ]
Re: Kudos
[ link to this | view in thread ]
Re: Kudos
"big victory for Teva and a major blow to Pfizer's Viagra empire"
[ link to this | view in thread ]
Competition may be under way also from the venom of wandering spiders :)
[ link to this | view in thread ]
Re:
[ link to this | view in thread ]
Suggestion for additional line
[ link to this | view in thread ]
Re: Re:
Well, on the funny side of things I just saw this comments elsewhere about the spider venom.
Quote:
Source: http://www.huffingtonpost.com/2012/08/29/spider-venom-viagra-brazilian-wandering_n_1840381.html
Q uote:"Cured in 20 minutes but you only get 40 minutes to use it before your dead. She had better be worth it.
- George , NY,NY, 30/8/2012 02:07"
Source:http://www.dailymail.co.uk/health/article-2195208/Venom-worlds-deadliest-spider-cure- erectile-dysfunction-20-minutes.html?ITO=1490
Quote:"It's amazing what you can find out on the web,,
- Silky , England, 29/8/2012 23:45"
Source: http://www.dailymail.co.uk/health/article-2195208/Venom-worlds-deadliest-spider-cure-erectile-dysfun ction-20-minutes.html?ITO=1490
Quote:"Oh the irony! A lifetime of erectile dysfunction which can only be cured by a spider which kills you in an hour! Suppose at least it would be the best hour of your life.
- Nikki , Bucks, 29/8/2012 22:35"
Source: http://www.dailymail.co.uk/health/article-2195208/Venom-worlds-deadliest-spider-cure-erectile-dysfun ction-20-minutes.html?ITO=1490
[ link to this | view in thread ]
And that is EXACTLY why design patents should not exist. Microsoft should not have a design patent on the shape of an xbox and more than Apple should have a design patent on the shape of a tablet.
There is not any knowledge being offered, it is merely for product differentiation which would be a under trademarks where it should be and is applicable.
[ link to this | view in thread ]
[ link to this | view in thread ]
Must resist innuendo
[ link to this | view in thread ]
Re: Must resist innuendo
[ link to this | view in thread ]
Re: Re: Must resist innuendo
[ link to this | view in thread ]
marketing patent?
[ link to this | view in thread ]
heaaaah
[ link to this | view in thread ]
Re: marketing patent?
[ link to this | view in thread ]
[ link to this | view in thread ]
[ link to this | view in thread ]
Re:
[ link to this | view in thread ]
[ link to this | view in thread ]
More patents need to be examined for disclosure
Does a patent on 1-click purchasing (Amazon), or Slide To Unlock (Apple), for example, disclose all of the technology involved?
[ link to this | view in thread ]
Re: Kudos
[ link to this | view in thread ]
Re: More patents need to be examined for disclosure
1) click
2) THERE IS NO #2!!!
Patent, please.
[ link to this | view in thread ]
Re: Re: marketing patent?
[ link to this | view in thread ]
[ link to this | view in thread ]
Re: Re: marketing patent?
[ link to this | view in thread ]
Re: Re: Kudos
[ link to this | view in thread ]
Re: Re: Kudos
[ link to this | view in thread ]
[ link to this | view in thread ]
ER Embarassment
[ link to this | view in thread ]
Re: Kudos
-------------------
http://www.nymalestripclub.org/male-strippers/black-male-strippers-nyc
[ link to this | view in thread ]
Re: Re: Re:
eat some Seaweed instead of
Viagra, YAY
now go the the HOs :)
[ link to this | view in thread ]
As far as I know, today you can buy Viagra OTC manufacture by Pfizer online with delivery to Canada.
[ link to this | view in thread ]